Clinical Trial: Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice
Study Status: Completed
Recruit Status: RECRUITING
Condition: Gallstone Disease
Study Type: OBSERVATIONAL
Official Title: Observational Study of Efficiency of the Drug Remaxol® (Inosine + Meglumine + Methionine + Nicotinamide + Succinic Acid) Used in the Treatment of Patients With Gallstone Disease Complicated With Obstr
Brief Summary:
Obstructive jaundice is observed in 10-80 % of gallstone disease cases.The conventional tactics for the management of patients with obstructive jaundice is to remove biliary hypertension by using endoscopic or minimally invasive methods.The final surgical treatment is performed after jaundice reduction and normalization of hepatic functions.We suppose that the administration of the drug Remaxol (Inosine + Meglumine + Methionine + Nicotinamide + Succinic acid) during the perioperative period shortens jaundice…
Read more